CIS bio outperforms ORIS with turnover up 14%
This article was originally published in Clinica
Turnover at French diagnostics manufacturer, CIS bio international rose 14% to top a billion francs in 1995. The growth was attributable mainly to the takeover of Behring's radiodiagnostic business. Sales outside France increased 27% in 1995 to represent two-thirds of the company's total sales.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.